Circe Biosciences Inc. — Form D
Circe Biosciences Inc. of SOMERVILLE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-21. The offering totals $4.0M, of which $1.6M was reported sold. Industry: Other.
Offering
- Filed: 2021-10-21
- Form: D
- Accession: 0001889271-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.6M
- Remaining: $2.4M
- Investors: 4
- Date of first sale: 2021-10-06
- Revenue range: Decline to Disclose
- SEC file number: 021-418077
Issuer
- Name: Circe Biosciences Inc.
- CIK: 0001889271
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 444 SOMERVILLE AVE, SOMERVILLE, MA, 02143
- Phone: 3603292832
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Shannon Nangle | Director | Allston, MA |
| Marika Ziesack | Director | Cambridge, MA |
| Shannon Nangle | Executive Officer | Allston, MA |
| Marika Ziesack | Executive Officer | Cambridge, MA |
| Shannon Nangle | Promoter | Allston, MA |
| Marika Ziesack | Promoter | Cambridge, MA |
More